[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100261164":3},{"organization":4,"armGroups":7,"interventions":39,"overallOfficials":60,"centralContacts":64,"locations":69,"responsibleParty":94,"collaborators":44,"id":97,"slug":98,"hasResults":99,"nctId":100,"briefTitle":101,"officialTitle":101,"acronym":102,"eligibilityCriteria":103,"healthyVolunteers":99,"sex":104,"minAge":105,"maxAge":106,"enrollmentInfo":107,"targetDuration":44,"studyType":110,"phases":111,"briefSummary":113,"conditions":114,"keywords":116,"overallStatus":72,"whyStopped":44,"lastUpdateSubmitDate":119,"lastUpdatePostDateStruct":120,"startDateStruct":123,"completionDateStruct":125,"leadSponsor":127,"locationsCount":128},{"fullName":5,"class":6},"Wenzhou Medical University","OTHER",[8,14,19,24,29,34],{"label":9,"type":10,"description":11,"interventionNames":12},"SN6AD1 group","ACTIVE_COMPARATOR","Bilateral cataract surgery with implantation of SN6AD1 multifocal IOLs",[13],"Device: SN6AD1",{"label":15,"type":10,"description":16,"interventionNames":17},"SBL-3 group","Bilateral cataract surgery with implantation of SBL-3 multifocal IOLs",[18],"Device: SBL-3",{"label":20,"type":10,"description":21,"interventionNames":22},"LS-313 MF30 group","Bilateral cataract surgery with implantation of LS-313 MF30 multifocal IOLs",[23],"Device: LS-313 MF30",{"label":25,"type":10,"description":26,"interventionNames":27},"AT LISA tri 839 MP group","Bilateral cataract surgery with implantation of AT LISA tri 839 MP multifocal IOLs",[28],"Device: AT LISA tri 839 MP",{"label":30,"type":10,"description":31,"interventionNames":32},"ART group","Bilateral cataract surgery with implantation of ART toric multifocal IOLs",[33],"Device: ART",{"label":35,"type":10,"description":36,"interventionNames":37},"LS-313 MF30T group","Bilateral cataract surgery with implantation of LS-313 MF30T toric multifocal IOLs",[38],"Device: LS-313 MF30T",[40,45,48,51,54,57],{"type":41,"name":42,"description":11,"armGroupLabels":43,"otherNames":44},"DEVICE","SN6AD1",[9],null,{"type":41,"name":46,"description":16,"armGroupLabels":47,"otherNames":44},"SBL-3",[15],{"type":41,"name":49,"description":21,"armGroupLabels":50,"otherNames":44},"LS-313 MF30",[20],{"type":41,"name":52,"description":26,"armGroupLabels":53,"otherNames":44},"AT LISA tri 839 MP",[25],{"type":41,"name":55,"description":31,"armGroupLabels":56,"otherNames":44},"ART",[30],{"type":41,"name":58,"description":36,"armGroupLabels":59,"otherNames":44},"LS-313 MF30T",[35],[61],{"name":62,"affiliation":5,"role":63},"AYong Yu, MD. PhD.","PRINCIPAL_INVESTIGATOR",[65],{"name":62,"role":66,"phone":67,"phoneExt":44,"email":68},"CONTACT","+86-0577-88068880","yaybetter@hotmail.com",[70],{"facility":71,"status":72,"city":73,"state":74,"zip":75,"country":76,"countryCode":77,"cosmosGeoPoint":78,"geoPoint":83,"contacts":84},"The Eye Hispital of Wenzhou Medical University","RECRUITING","Wenzhou","Zhejiang","325000","China","CN",{"type":79,"coordinates":80},"Point",[81,82],120.66682,27.99942,{"lat":82,"lon":81},[85,89,92],{"name":86,"role":66,"phone":87,"phoneExt":44,"email":88},"Anpeng Pan, MD.OD.","+86-577-88068809","pananpeng@126.com",{"name":90,"role":91,"phone":44,"phoneExt":44,"email":44},"Shuangqian Zhu, MD.","SUB_INVESTIGATOR",{"name":93,"role":91,"phone":44,"phoneExt":44,"email":44},"Kaijing Zhou, MD.PhD.",{"type":63,"investigatorFullName":95,"investigatorTitle":96,"investigatorAffiliation":5,"oldNameTitle":44,"oldOrganization":44},"A-Yong Yu","Clinical Professor","100261164","comparison-of-outcomes-with-multifocal-intraocular-lenses-100261164",false,"NCT02678962","Comparison of Outcomes With Multifocal Intraocular Lenses","COMIL","Inclusion Criteria:\n\n* Age from 40 to 80 years old, either gender;\n* Patients with bilateral age related cataracts, require bilateral cataract phacoemulsification combined Intraocular Lens implantation;\n* Willing to undergo second eye surgery within 7 days after first eye surgery;\n* The potential postoperative visual acuity of 20\u002F40 or better in both eyes;\n* Preoperative measurement of corneal astigmatism indicate the subjects are suitable for multifocal intraocular lenses implantation;\n* Capability to understand the informed consent and willing and able to attend study\n\nExclusion Criteria:\n\n* Preexisting ocular diseases or conditions other than age related cataracts, have contraindications for cataract surgery;\n* Preexisting systemic diseases or conditions that may confound the results of the study;\n* Previous ocular surgery history or ocular trauma that may confound the results of the study;\n* Require combined surgery that may confound the results of the study;\n* Previous participation in other clinical trial within 30 days of this study start;\n* Systemic or ocular medications that may confound the outcome of the intervention\n* Pregnant, lactating, or planning to become pregnant during the course of the trial;","ALL","40 Years","80 Years",{"count":108,"type":109},90,"ESTIMATED","INTERVENTIONAL",[112],"NA","The purpose of this study is to compare and evaluate the clinical outcomes of 6 kinds of Multifocal Intraocular Lenses: SN6AD1, SBL-3, LS-313 MF30, AT LISA tri 839 MP, ART, LS-313 MF30T.",[115],"Cataract",[117,118],"Multifocal Intraocular Lenses","bilateral implantation","2024-07-22",{"date":121,"type":122},"2024-07-23","ACTUAL",{"date":124,"type":44},"2016-02",{"date":126,"type":109},"2026-06",{"name":5,"class":6},1]